Radiotherapy in limited small cell lung cancer: Fractionation and timing of modalities
- 1 January 1995
- journal article
- Published by Elsevier in Seminars in Radiation Oncology
- Vol. 5 (1) , 50-56
- https://doi.org/10.1016/s1053-4296(05)80010-4
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Chemotherapy in small cell lung cancer: The current state of the artSeminars in Radiation Oncology, 1995
- Prophylactic cranial irradiation: More questions than answersSeminars in Radiation Oncology, 1995
- Small cell lung cancer: The influence of dose and treatment volume on outcomeSeminars in Radiation Oncology, 1995
- A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung CancerNew England Journal of Medicine, 1992
- On the origin of dose fractionation regimens in radiotherapySeminars in Radiation Oncology, 1992
- Editors' commentsSeminars in Radiation Oncology, 1992
- Limited (LTD) Stage Small Cell Lung Cancer (SCLC) treated with concurrent BID chest radiotherapy (RT) and etoposide cisplatin (VP/PT) followed by chemotherapy (CT) selected by in vitro Drug Sensitivity Testing (DST): B.E. Johnson, C. Salem, J. Nesbitt, A.F. Gazdar, M. Lesar, R. Phelps, M. Edison, R.I. Linnolla, J. Phares, H. Pass, J. Mulshine, J.D. Minna, E. Glatstein, D.C. Ihde. NCI-Navy Med., Rad. Oncol. and Surg. Br, NCI, Surg. and Rad. Dep., Nav. Hosp. and USUHS, Bethesda, MD 20889-5105Lung Cancer, 1991
- Accelerated Hyperfractionated Split-Course Thoracic Radiotherapy (AHSCTRT) and infusion cisplatin based Chemotherapy (CT) for Small Cell Lung Cancer (SCLC)Lung Cancer, 1991
- Chemotherapy with or without Radiation Therapy in Limited Small-Cell Carcinoma of the LungNew England Journal of Medicine, 1987
- Combination cis-platinum and etoposide in small-cell lung cancerCancer Treatment Reviews, 1982